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011.08.0Abstract Introduction: CRT had become a standard of treatment for patients with drug refrac-
tory heart failure. The presence of many cases of non-responders raises the need for device optimi-
zation echocardiography that is an established tool used to optimize CRT programming, but it is
time-consuming. It was not yet deﬁned whether a QRS width-based strategy may be a helpful tool
for device programming.
Aim of study: The aim of this study is to compare the optimal interventricular delay interval (V–V
interval) obtained by echo with that obtained by a simpler method using QRS width in surface
ECG.
Methods and results: Twenty patients with implanted CRT were enrolled. All patients underwent
echocardiographic optimization of the (A–V interval) after which ﬁve different V–V intervals
(LV + 30, LV + 60, RV + 30, RV + 60, L + R0) were compared measuring Left Ventricular
Outﬂow Tract Velocity Time Integral (LVOT VTI) as a surrogate for ejection fraction. A 12-lead
ECG was recorded and QRS duration was measured in the lead with the greatest QRS width. The
ECG optimized V–V interval was deﬁned according to the narrowest achievable QRS interval
among the 5 V–V intervals. The echocardiographic-optimized V–V interval was deﬁned according
to the highest LVOT VTI among the 5 V–V intervals. The echocardiographic-optimized V–V inter-
val was left ventricle + 30 ms in 2 patients (10%), left ventricle + 60 ms in 8 pts (40%), simulta-
neous pacing in 8 pts (40%) and right ventricle + 30 ms in 2 pts (10%).
ECG method (using QRS width), had 85% coincidence with the echocardiographic method (using
LVOT VTI) (j= 0.906), (r= 0.81 P< 0.001).(D. Ragab).
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128 A. Nawar et al.Conclusion: Signiﬁcant correlation appeared to exist during optimization of CRT between VV pro-
gramming based on the shortest QRS interval at 12-lead ECG pacing and that based on highest
LVOT VTI by echocardiography. A combined ECG and echocardiographic approach could be a
more convenient solution in performing V–V optimization.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Cardiac resynchronization therapy (CRT) has emerged rap-
idly as a therapeutic option for patients with drug-refractory
heart failure. After this therapy, most patients show improve-
ment in heart failure symptoms, exercise capacity, and left
ventricular (LV) systolic performance. Moreover, a decrease
in rehospitalization for heart failure and improved long-term
survival compared with optimal medical therapy has been
demonstrated.1–5
1.1. Current selection criteria for patients eligible for CRT include
 Moderate to severe heart failure (New York Heart Associ-
ation [NYHA] classes III–IV) despite optimal medical
therapy.
 Systolic dysfunction (LV ejection fraction [LVEF] <35%).
 Wide QRS complex (QRS duration >120 ms).6,7
Despite these selection criteria and although the clinical
results of CRT are promising, analysis of individual responses
has revealed that almost 30% of patients do not exhibit any
symptomatic or hemodynamic improvement: the so-called
‘non-responders’.8–10 One of the reasons for this may be sub-
optimal programming of the device, which has particular con-
siderations as compared to standard pacemakers.11
The recent generation of CRT devices allowed optimization
of the V–V interval because of the availability of interventricu-
lar offset. In daily practice, echocardiographic assessment of
cardiac output using the left ventricular outﬂow velocity time
integral at different V–V intervals may be the preferred
approach to assess optimal V–V settings. Adjustment of inter-
ventricular pacing intervals further improved cardiac perfor-
mance compared with simultaneous biventricular pacing in a
relevant subgroup of patients.12
Although echocardiography is the most widely used tech-
nique to optimize CRT, the process is time-consuming and,
as yet, not well standardized. It was conceivable that an alter-
native method could be sought, which proved reliable, non-
operator dependent, inexpensive, and suitable to become a
built-in feature of a CRT device.13–15
A wide QRS has traditionally been used as a marker of
patients with mechanical dyssynchrony. Although relatively
good correlation between interventricular dyssynchrony and
QRS duration has been reported, no signiﬁcant correlation ex-
isted between intraventricular dyssynchrony and QRS width.16
The ECG-optimized V–V interval is therefore deemed to be
related to the least interventricular dyssynchrony. According
to published reports, the greatest QRS width was deemed to
reﬂect interventricular mechanical dyssynchrony.17We aimed in this work to correlate the optimal interven-
tricular (V–V) pacing interval obtained by echo (highest
LVOT VTI) with the optimal V–V interval obtained by a
simpler method based on the surface ECG (Narrowest QRS
width).2. Patients
Over a period of one year from January 2009 to January 2010,
we studied 20 patients with sequential activation capability
biventricular pacing system. They included 17 males and 3
females.
Ten patients were studied at the Critical care Department,
Cairo University from the period of January 2009 till August
2009, while the other 10 patients were studied at the pacemaker
follow-up clinic at the Department of Cardiology, University
of Brescia, Italy.
 The following patients were excluded from the study: those
with recent ischemic episode or correctable coronary heart
disease, frequent atrial and/or ventricular premature beats,
suboptimal echocardiographic window with poor image
quality, uncorrected valvular disease or dysfunctional pros-
thetic valve, severe primary pulmonary disease, and those
with atrial ﬁbrillation.
3. Methods
3.1. Echocardiography study
All patients were subjected to transthoracic echocardiographic
examination using ATL.HDI 5000 colored echocardiographic
machine using a 3.5 MHz transducer.
An apical 5 chamber view was obtained, color ﬂow and
pulsed wave (PW) Doppler was positioned in the LVOT with
calculation of VTI. The left ventricular outﬂow tract (LVOT)
velocity time integral (VTI) was measured at baseline and at
ﬁve different V–V intervals (L + R 30, L + R 60, L + R 0,
R + L 30, R+ L 60).
The LVOT VTI is considered as a surrogate of stroke vol-
ume according to the following equation:
Flow rate = CSA (cross sectional area) · ﬂow velocity.
SV (stroke volume) = CSA · VTI.
CO (cardiac output) = SV · HR.
The echocardiographic – optimized V–V interval is deﬁned
as that corresponding to the maximum LVOT ﬂow velocity
integral measured in cm (Fig. 1).
Figure 1 Simultaneous left and right ventricular pacing showing QRS width at lead V2 was 160 ms and aortic ﬂow velocity was 7.1.
Table 1 Population baseline characteristics, values expressed
as mean ± SD, percent, or number (percent).
Age (yrs) 58.55 ± 14.04
Sex
Males 85% (17)
Females 15% (3)
New York Heart Association class
III 90% (18)
IV 10% (2)
Underlying cause of heart failure
Ischemic 55% (11)
Non-ischemic 45% (9)
QRS width (ms) 169.5 ± 20.12
Left ventricular EF (%) 31.75 ± 5.53
Left ventricular end-diastolic diameter (cm) 6.88 ± 0.57
Left ventricular end-systolic diameter (cm) 5.67 ± 0.64
Risk factors
DM 11 (55%)
HTN 11 (55%)
Smoking 10 (50%)
Duration of implant range in months 3.11 ± 2.86
Type of PM
CRT-P 16 (80%)
CRT-D 4 (20%)
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At each of the ﬁve tested V–V intervals, a 12-lead electrocar-
diogram was recorded at a paper speed of 50 mm/s and a 10-
mm/mV gain, and QRS duration in ms. was measured in the
lead with the greatest QRS width from the ﬁrst deﬂection
of the QRS complex to its terminal isoelectric component
(Fig. 1).
The electrocardiographic (ECG) – optimized V–V interval
is deﬁned as that corresponding to the narrowest QRS in these
ﬁve measurements.
QRS duration was assessed manually using a graduated
measuring instrument with accuracy of 0.25 mm (10 ms) in
the lead with the widest QRS width at the 5 VV offsets.
4. Results
4.1. Baseline characteristics (Table 1)
4.2. ECG optimized V–V interval
After performing an ECG with each of the ﬁve V–V delays, the
ECG optimized V–V interval as deﬁned by the narrowest QRS
width was as follows.
Ten patients (50%) had the narrowest QRS with simulta-
neous biventricular pacing, 8 patients (40%) with left ventric-
ular preactivation at 60 ms, and the remaining 2 patients
(10%) with left preactivation at 30 ms (Table 2).
4.3. Echocardiographic results
The echocardiographic optimized V–V (deﬁned as the highest
LVOT VTI) at different settings of V–V interval programming
was as follows.
Eight patients (40%) obtained the highest LVOT VTI read-
ing with simultaneous biventricular pacing (L + R 0), 8 pa-
tients (40%) obtained it with left ventricular preactivation of
60 ms (L + R 60), 2 patients (10%) had their highest readingwith left preactivation of 30 ms (L + R 30), the remaining 2
patients (10%) obtained the highest LVOT VTI with right ven-
tricular preactivation of 30 ms (R + L 30) (Table 2).
4.4. Comparison between echocardiographic and
electrocardiographic optimization of V–V interval
When comparing the echo and ECG optimized V–V interval,
concordance between the two methods occurred in 17 patients
(85%).
Table 2 ECG and echocardiography optimized V–V interval.
ECG optimized V–V interval No. of patients Percent Echo optimized V–V interval No. of patients Percent (%)
L + R 0 10 50 L + R 0 8 40
L + R 60 8 40 L + R 60 8 40
L + R 30 2 10 L + R 30 2 10
R + L 30 0 0 R + L 30 2 10
Table 3 Cross tabulation between ECHO and ECG results.
V–V interval L + R 0 L + R 30 L + R 60 R + L 30 Total
L + R 0 8 0 1 1 10
L + R 30 0 2 0 0 2
L + R 60 0 0 7 1 8
Total 8 2 8 2 20
130 A. Nawar et al.The cross-tabulation between the 2 methods revealed Sub-
stantial concordance (j= 0.906) between the ECHO opti-
mized and ECG optimized V–V interval. P value <0.001,
Table 3.
4.5. Correlation between ECG and ECHO in determining the
optimal V–V interval
There was high correlation between echo optimized V–V inter-
val and ECG optimized V–V interval with r= 0.756 with
P-value <0.001 (Fig. 2).
4.6. ECG optimized V–V interval and Ischemic heart disease
Patients were divided according to the presence (Group I) or
absence (Group II) of ischemic heart disease:
I – Group I (11 patients): 6 patients (54.5%) obtained the
narrowest QRS width with left ventricular preactivation
at 60 ms, 4 patients (36.4%) with simultaneous biventricu-
lar pacing and ﬁnally 1 patient (9%) with left ventricular
preactivation at 30 ms.Figure 2 Correlation between ECG and ECHO.II – Group II (9 patients): 6 patients (66.7%) had their
narrowest QRS width with simultaneous biventricular
pacing, 2 patients (22.2%) with left preactivation at
60 ms, and 1 patient (11.1%) with left preactivation at
30 ms (Table 4).
4.7. Echocardiographic optimized V–V interval and ischemic
heart disease
I – Group I (11 patients): 6 patients (54.5%) obtained the
highest LVOT VTI with left ventricular preactivation at
60 ms, 3 patients (27.3%) with simultaneous biventricular
pacing, 1 patient (9.1%) with left ventricular preactivation
at 30 ms, and ﬁnally 1 patient (9.1%) with right ventricular
preactivation at 30 ms.
Group II (9 patients): 5 patients (55.6%) had their highest
Aortic ﬂow velocity with simultaneous biventricular pacing, 2
patients (22.2%) with left preactivation at 60 ms, and 1 patient
(11.1%) with left preactivation at 30 ms, ﬁnally 1 patient
(11.1%) obtained the highest reading with right ventricular
preactivation of 30 ms (Table 5).
4.8. Concordance and ischemic heart disease
Group I (11 patients): 9 patients (81.8%) had concordance be-
tween the echocardiographic and ECG-optimized V–V inter-
val, while in 2 patients (18.2%) there was no concordance
observed.Table 4 Relation between IHD and ECG optimized V–V
interval.
V–V interval Group I Group II P-value
L + R 0 4 (36.4%) 6 (66.7%) 0.329
L + R 30 1 (9.1%) 1 (11.1%)
L + R 60 6 (54.5%) 2 (22.2%)
Total 11 9
Table 5 Effect of IHD on ECG optimized V–V interval.
V–V interval Group I Group II P-value
L + R 0 3 (27.3%) 5 (55.6%) 0.508
L + R 30 1 (9.1%) 1 (11.1%)
L + R 60 6 (54.5%) 2 (22.2%)
R + L 30 1 (9.1%) 1 (11.1%)
Total 11 9
Table 6 Concordant patients and IHD.
Concordance Group I Group II P-value
YES 9 (81.8%) 8 (88.9%) 1.0
NO 2 (18.2%) 1 (11.1%)
Total 11 9
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between the echocardiographic and ECG-optimized V–V
interval, while in 1 patient (11.1%) there was no concordance
observed P-value = 1.000 (Table 6).
5. Discussion
In our study, we found that 17 patients (85%) had concordance
between echo and ECG optimized V–V interval. A substantial
agreement between these two methods used to optimize the V–
V interval of CRT devices (weighted j= 0.906, P< 0.001).
Optimizing CRT devices with this ECG parameter showed a
good correlation with the results obtained via echo-guided opti-
mization of V–V interval (r= 0.756 with P-value <0.001).
Our results are in agreement with the study conducted by
Bertini et al.18 who found a signiﬁcant concordance during
biventricular pacing between V–V programming based on
the shortest QRS interval at 12-lead ECG pacing and echocar-
diographic-guided V–V interval optimization using LVOT VTI
and recommended that a combined ECG- and echocardio-
graphic approach could be a less time-consuming solution in
performing this operation.
In contrast Vidal et al.,19 reported a poor correlation be-
tween the V–V interval that produced the narrowest QRS
interval (measured from the pacing artifact) and the V–V inter-
val that obtained the best interventricular resynchronization
according to tissue Doppler measurement.
The disagreement could be explained that Vidal et al.,19
optimized the VV interval with a different method than that
used in our study. Also, in our study we measured the QRS
width from the ﬁrst deﬂection, avoiding the initial isoelectric
portion, While Vidal et al.19 measured from the beginning of
the pacing artifacts, in this latter ECG method there is an over-
estimation of QRS duration that may change at the different
VV intervals tested, potentially affecting the ﬁnal results.
At present, echocardiography is the most used technique to
optimize CRT pacing, and the QRS duration is considered an
oversimpliﬁed surrogate marker of mechanical dyssynchro-
ny.20 although most investigators use the velocity–time integral
method, several echocardiographic measurements have been
described for performing VV optimization. However, all re-
quire time and expertise.
20–22The maximal VTI by echo was found to be with LV preac-
tivation in 50% (10 patients), 40% (8 patients) with simulta-
neous pacing (L + R= 0) and the remaining 2 patients with
RV preactivation.
The optimum V–V interval involved in most patients was
with LV preactivation in the studies conducted by Perego
et al.23 and van Gelder et al.24 who obtained, respectively,
75% and 83% of LV preactivation as the optimal V–V interval
in a similar group of patients with heart failure, systolic LV
dysfunction, and LBBB conﬁguration.
This is logical up to a certain point because all patients had
a LBBB conﬁguration, suggesting that the latest activation is
located at the left lateral wall, and that pacing from the epicar-
dium will have a delay of about 30–40 ms that should be
corrected.
Burri et al.25 investigated the role of sequential VV pacing
in improving LVEF in 27 patients with heart failure using
radionuclide ventriculography. Simultaneous biventricular
pacing yielded maximal LVEF in only 33% of patients. A rel-
ative increase in LVEF of 18% by optimized sequential pacing
was observed in the remaining patients. A signiﬁcant impact
on interventricular dyssynchrony but not intraventricular dys-
synchrony by sequential VV pacing was observed in this study.
In normal hearts, the activation of the two ventricles does
not occur simultaneously (i.e. epicardial RV depolarization
starts a few milliseconds earlier than LV depolarization).26
Second, in CRT, the left ventricle is paced from the epicardial
side, and this could account for a delay in the transmission of
the stimulus that needs to reach the subendocardial conduction
system before spreading to the remaining ventricle.
Finally, the ventricular leads (particularly LV leads) are
placed in quite different anatomical positions, depending on
the operator’s choice and coronary sinus anatomy, leading to
ventricular activation patterns during pacing that differ from
patient to patient.27
In our study population, there were 11 patients with under-
lying ischemic heart disease and 9 patients with no evidence of
ischemia. Within the ischemic group, it was noted that there
was a higher prevalence of LV preactivation as in 63% of pa-
tients (7 patients) had their optimal V–V delay with LV preac-
tivation, while 27% (3 patients) had their optimal V–V interval
with simultaneous pacing, only 1 patient had RV preactivation.
In non-ischemic group however 55.6% of patients had their
optimal delay with simultaneous pacing 33% 3 patients with
left preactivation, ﬁnally 1 patient (11.1%) obtained the high-
est reading with RV preactivation.
However, there was no statistically signiﬁcant difference be-
tween ischemic and non ischemic groups as regards VV inter-
val activation sequence the P-value was not signiﬁcant (0.508).
Similarly Bertini et al.18 and Vidal et al.19 did not ﬁnd a dif-
ference or prevalent mode between ischemic patients and non-
ischemic patients.
Myocardial disease is associated with different locations and
sizes of scars, and heterogeneity of conduction disturbances.
The baseline ventricular conduction defect differs considerably
from case to case, especially in patients with a QRS duration
>150 ms.
Theoretically, there is a slow conduction in the presence of
scar tissue in ischemic cardiomyopathy and this necessitate
more LV pre-excitation for further improvement of the overall
response to CRT.28
132 A. Nawar et al.Sogaard et al.29 used Doppler imaging techniques, studied
21 patients with LBBB, QRS >130 ms, and New York Heart
Association (NYHA) functional class III or IV heart failure,
they deﬁned a new parameter that they called the extent of
delayed LV longitudinal contraction (DLC), this is calculated
using tissue Doppler imaging (TDI) coupled with strain rate
analysis.29
A segment was considered to have DLC if the strain rate
analysis demonstrated motion reﬂecting true contraction and
if the end of the segmental contraction occurred after aortic
valve closure. DLC in patients with idiopathic dilated cardio-
myopathy was identiﬁed in the lateral and posterior LV walls.
In contrast, ischemic cardiomyopathy exhibited DLC more
frequently in the septal and inferior walls.29
They concluded that the location of DLC predicted the
optimal sequential CRT as posterior lateral wall DLC was
associated with optimal sequential CRT via LV pre-activation,
while septal and inferior wall-DLC was associated with opti-
mal sequential CRT via RV preactivation.29
The practical interest of our study was the possibility of
using a combined approach for VV interval optimization, of
course, ECG cannot provide complementary information
regarding LV dimensions, volumes, function, and synchrony
in the way echocardiography does. However, our results show
that ECG optimization using a simple measurement is possible
and offers an easy way to estimate the optimum V–V interval.
Furthermore, the measurements can be done immediately after
device implantation, even in the operating room, thus obtain-
ing a good correlation with echo in more than 80% of patients
with LBBB conﬁguration.
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